Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

4,700

Employees4,700

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

4,700

Employees4,700

MRNA Key Statistics

Market cap

18.61B

Market cap18.61B

Price-Earnings ratio

-5.75

Price-Earnings ratio-5.75

Dividend yield

—

Dividend yield—

Average volume

8.33M

Average volume8.33M

High today

$48.35

High today$48.35

Low today

$46.77

Low today$46.77

Open price

$47.54

Open price$47.54

Volume

4.22M

Volume4.22M

52 Week high

$59.55

52 Week high$59.55

52 Week low

$22.28

52 Week low$22.28

Stock Snapshot

Moderna(MRNA) stock is priced at $46.85, giving the company a market capitalization of 18.61B. It carries a P/E multiple of -5.75.

On 2026-05-24, Moderna(MRNA) stock moved within a range of $46.77 to $48.35. With shares now at $46.85, the stock is trading +0.2% above its intraday low and -3.1% below the session's peak.

Trading volume for Moderna(MRNA) stock has reached 4.22M, versus its average volume of 8.33M.

Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $59.55 and a low of $22.28.

MRNA News

TipRanks 1d

JPMorgan, Chevron, Strategy, Moderna, Snap Insider Shake-Up

Insiders have been trading these 5 stocks: ((JPM)), ((CVX)), ((MSTR)), ((MRNA)) and ((SNAP)). Here is a breakdown of their recent trades and their value. Start...

CNN 2d

MRNA Stock Quote Price and Forecast - CNN

...

Benzinga 3d

Moderna Flu Shot Heads To FDA Advisory Panel

Citing a notice, Bloomberg reported that the FDA scheduled the advisory committee meeting for June 18. In February, the FDA issued a refusal-to-file letter reg...

Analyst ratings

63%

of 27 ratings

Buy

18.5%

Hold

63%

Sell

18.5%

More MRNA News

Seeking Alpha 3d

Moderna to face FDA AdCom review for flu shot

Moderna’s (MRNA) marketing application for its flu vaccine, mRNA-1010, will be reviewed by the FDA's independent experts next month, according to a federal noti...

24/7 Wall St. 3d

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Gilead Sciences wasn't one of them. Get them here FREE . Gilead Sciences (GILD) more tha...

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.